| 2025-12-05 |
详情>>
内部人交易：
Dhingra Gagan等共交易3笔
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本32416.85万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-8.15美元,归母净利润-25.05亿美元,同比去年增长-3.31%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘后发布财报
|
| 2025-08-30 |
复牌提示：
2025-08-29 19:50:00 停牌，复牌日期 2025-09-02 09:00:00
|
| 2025-08-21 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益-0.48美元,归母净利润-14.7亿美元,同比去年增长0.32%
|
| 2025-07-28 |
股东大会：
将于2025-08-18召开股东大会
会议内容 ▼▲
- 1.Approval of an amendment to the Company’s Third Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s Class A common stock.
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益-0.24美元,归母净利润-7.31亿美元,同比去年增长-6.77%
|
| 2025-04-24 |
股东大会：
将于2025-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees to serve as directors, to hold office until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier death, resignation or removal;
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To approve, on an advisory basis, the compensation for our named executive officers;
4.To approve the amendment and restatement of the Lucid Group, Inc. Amended and Restated 2021 Stock Incentive Plan;
5.To conduct such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2025-02-25 |
详情>>
业绩披露：
2022年年报每股收益-0.78美元,归母净利润-25.59亿美元,同比去年增长46.10%
|
| 2025-02-25 |
详情>>
业绩披露：
2024年年报每股收益-1.25美元,归母净利润-30.62亿美元,同比去年增长-8.24%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.05美元,归母净利润-24.25亿美元,同比去年增长-11.5%
|
| 2024-08-05 |
详情>>
业绩披露：
2024年中报每股收益-0.64美元,归母净利润-14.75亿美元,同比去年增长4.45%
|
| 2024-08-05 |
详情>>
业绩披露：
2023年中报每股收益-0.82美元,归母净利润-15.44亿美元,同比去年增长-411.67%
|
| 2024-05-06 |
详情>>
业绩披露：
2024年一季报每股收益-0.3美元,归母净利润-6.85亿美元,同比去年增长12.16%
|
| 2024-04-25 |
股东大会：
将于2024-06-04召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees to serve as directors, to hold office until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier death, resignation or removal;
2.To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve, on an advisory basis, the compensation for our named executive officers;
4.To approve the amendment and restatement of the Lucid Group, Inc. Second Amended and Restated 2021 Stock Incentive Plan;
5.To conduct such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益-1.36美元,归母净利润-28.28亿美元,同比去年增长-10.54%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.08美元,归母净利润-21.75亿美元,同比去年增长-161.44%
|
| 2023-03-13 |
股东大会：
将于2023-04-24召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees to serve as directors, to hold office until the 2024 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier death, resignation or removal;
2.To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To approve, on an advisory basis, the compensation for our named executive officers;
4.To approve the amendment of the Lucid Group, Inc. Amended and Restated 2021 Stock Incentive Plan;
5.To approve the amendment and restatement of the Company’s current certificate of incorporation (the “Third Amended and Restated Certificate of Incorporation”);
6.To conduct such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2022-04-28 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees to serve as directors until the next annual meeting of stockholders and until their successors are duly elected and qualified, subject to earlier resignation or removal;
2.To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To approve, on an advisory basis, the compensation for our named executive officers;
4.To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers;
5.To approve the amendment of the Lucid Group, Inc. 2021 Stock Incentive Plan;
6.To conduct such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-25 |
股东大会：
将于2021-07-22召开股东大会
会议内容 ▼▲
- 1.a proposal to approve the business combination described in the accompanying proxy statement/prospectus, including (a) adopting the Merger Agreement and (b) approving the other transactions contemplated by the Merger Agreement and related agreements described in the accompanying proxy statement/prospectus—we refer to this proposal as the “business combination proposal”;
2.a proposal to approve and adopt the second amended and restated certificate of incorporation of Churchill in the form attached hereto as Annex B (the “second amended and restated certificate of incorporation”)—we refer to this proposal as the “charter proposal”;
3.a proposal to approve, on a non-binding advisory basis, certain governance provisions in the second amended and restated certificate of incorporation, presented separately in accordance with the United States Securities and Exchange Commission (“SEC”) requirements - we refer to this proposal as the “governance proposal”;
4.a proposal to approve and adopt the Lucid Group, Inc. 2021 Stock Incentive Plan, including the Lucid Group, Inc. 2021 Employee Stock Purchase Plan attached thereto (the “Incentive Plan”), and the material terms thereof, including the authorization of the initial share reserve thereunder — we refer to this proposal as the “incentive plan proposal.” A copy of the Incentive Plan is attached to the accompanying proxy statement/prospectus as Annex H;
5.a proposal to elect nine directors to serve on the Churchill Board for a term ending on the date of the next annual stockholder meeting, or until their respective successors are duly elected and qualified—we refer to this proposal as the “director election proposal”;
6.a proposal to approve, for purposes of complying with the applicable provisions of Section 312.03 of the NYSE’s (as defined below) Listed Company Manual, (a) the issuance of more than 20% of Churchill’s issued and outstanding shares of common stock in connection with the Transactions, including, without limitation, the PIPE Investment (as described below) and the issuance of more than 20% of Churchill’s issued and outstanding shares to a single holder (which may constitute a change of control under the NYSE’s Listed Company Manual) and (b) the issuance of shares of Churchill’s Class A common stock to a Related Party (as defined in Section 312.03 of the NYSE’s Listed Company Manual) in connection with the Transactions—we refer to this proposal as the “NYSE proposal”;
7.a proposal to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the business combination proposal, the charter proposal, the governance proposal, the incentive plan proposal, the director election proposal or the NYSE proposal—we refer to this proposal as the “adjournment proposal.”
|